Nutrition impact of peritoneal dialysis solutions

Mineral and Electrolyte Metabolism

Volumn 25, Issue 4-6, 1999, Pages 333-336

  Wolfson, Marsha ^a   Jones, Michael R ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Amino acids; Glucose; Glucose polymer; Icodextrin; Lactate; Nutrition; Peritoneal dialysis

Indexed keywords

AMINO ACID; BICARBONATE; ELECTROLYTE; GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; LACTATE SODIUM; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID;

ANOREXIA; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG FORMULATION; HOSPITALIZATION; HUMAN; MALNUTRITION; METABOLIC DISORDER; MUSCLE MASS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; ULTRAFILTRATION; WEIGHT GAIN;

EID: 0033369938     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057469     Document Type: Conference Paper

References (24)

1. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996;97:1447-1453.
2. England BK, Greiber S, Mitch WE, Bowers BA, Herring WJ, McKean M, Ebb RG, Price SR, Danner DJ: Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 1995;268:C1395-C1400.
3. Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, Troughton J, Bircher G, Walls J: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 1997;52:1089-1095.
4. Kang DH, Yoon KI, Lee HY, Han DS: Impact of peritoneal membrane transport characteristics on acid-base status in CAPD patients. Perit Dial Int 1998;18:294-302.
5. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-1292.
6. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981;9:564-567.
7. Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989;35:704-711.
8. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993;44:1048-1057.
9. Boeschoten EW, Zuyderhoudt FMJ, Krediet RT, Arisz L: Changes in weight and lipid concentrations during CAPD treatment. Perit Dial Int 1988;8:19-24.
10. Lameire N, Mathys D, Mathys E, Beheydt R: Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988;30: S53-S58.
11. Lindholm B, Karlander SG, Norbeck HE, Bergström J: Hormonal and metabolic adaptation to the glucose load of PD in non-diabetic patients; in Keen H, Legrain M (eds): Prevention and Treatment of Diabetic Nephropathy. Boston, MTP Press Ltd, 1983, pp 353-359.
12. Mistry CD, Gokal R, Peers E, MIDAS Study Group: A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994;46:496-503.
13. Young GA, Brownjohn AM, Parsons FM: Protein losses in patients receiving continuous ambulatory peritoneal dialysis. Nephron 1987;45: 196-201.
14. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 1981;19:593-602.
15. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982; 36:395-402.
16. Blumenkrantz M, Kopple J, Moran J, Coburn J: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1982;21:849-861.
17. Heimbürger O, Lindholm B, Bergström J: Chapter 21. Nutritional effects and nutritional management of chronic peritoneal dialysis. Baltimore, Williams & Wilkins, 1997, pp 619-668.
18. Jones M, Gehr T, Burkart J, Hamburger R, Kraus A, Piraino B, Hagen T, Ogrine F, Wolfson M: Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 1998;18:210-216.
19. Twardowski ZG, Nolph KD, Khanna R: Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-147.
20. Kopple JD, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, Stegink LD, Martis L, Algrim Boyle C, Serkes KD, Vonesh E, Jones MR: Treatment of malnourished PD patients with an amino acid based dialysate. Kidney Int 1995;47:1148-1157.
21. Faller B, Aparicio M, Faict D, De Vos C, de Precigout V, Larroumet N, Guiberteau R, Jones M, Peluso F: Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Neph Dial Transplant 1995;10:1432-1437.
22. Jones M, Hagen T, Algrim Boyle C, Vonesh E, Hamburger R, Charytan C, Sandroni S, Bernard D, Piraino B, Schreiber M, Gehr T, Fein P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraus A, McDonald L, Hartnett M, Weaver M, Martis L, Moran J: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis (in press).
23. Thissen J-P, Ketelslegers J-M, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 1994;15:80-101.
24. Brem AS, Maaz D, Shemin DG, Wolfson M: Use of amino acid peritoneal dialysate for one year in a child on CCPD. Perit Dial Int 1996; 16:634-636.